Announcements Trials
Browse Landscape

Phase

Phase 2/3 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2Other hematologic neoplasm 2Lymphoid 2

Conditions

Neoplasms, Plasma Cell 2Neoplasms 2Lymphoma 2Leukemia 2Infections 2Hematologic Neoplasms 2Multiple Myeloma 1Lymphoma, Non-Hodgkin 1

Interventions

Trimethoprim, Sulfamethoxazole Drug Combination 5Ciprofloxacin 4gamma-Globulins 3Caspofungin 3Amoxicillin-Potassium Clavulanate Combination 3liposomal amphotericin B 2Voriconazole 2Polymerase Chain Reaction 2Pentetic Acid 2Moxifloxacin 2Levofloxacin 2Itraconazole 2Immunoglobulins, Intravenous 2Fluconazole 2talquetamab 1idecabtagene vicleucel 1gilteritinib 1fludarabine phosphate 1ethanolamine oleate 1drotrecogin alfa activated 1amphotericin B, deoxycholate drug combination 1X-Rays 1Whole-Body Irradiation 1Watchful Waiting 1Vancomycin 1Valacyclovir 1Trimethoprim 1Therapeutics 1Tazobactam 1Tacrolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Infections × Immunoglobulins, Intravenous × Other hematologic neoplasm × Clear all
NCT07202052 2025-10-07

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)

Monash University

Phase 2/3 Recruiting
900 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Infections, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Neoplasms, Neoplasms, Plasma Cell

NCT07202065 2025-10-07

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Dosing Immunoglobulin (Dose Ig)

Monash University

Phase 2/3 Recruiting
900 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Infections, Leukemia, Lymphoma, Neoplasms, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡